The Immune Endocrine and Epigenetics focuses on the molecular mechanisms underlying the environmental control of phenotype development.
Stress represents the single most important cause of disease, causing costs as high as 3-4 % of the European GNP, and up to 60% of all work-days lost to disease. Many of these diseases are related to infections and aberrant immune reactions. Our interest is in elucidating genetic, epigenetic, transcriptional, translation and post-translational mechanisms underlying environmental control of the stress reaction, particularly within the negative feedback loop of the HPA (hypothalamic–pituitary–adrenal) axis.
The main goal of our research is to understand the molecular mechanisms underlying the environmental control of phenotype development, in the HPA axis and in the immune system.
“Forschungsinstitut für Psychobiologie des Stresses” University Trier
Research Unit INSIDE, University of Luxembourg
Leiden-Amsterdam Centre for Drug Research (LACDR)
Department of Periodontology University of Oslo & Department of Medical Psychology, Bergen, Norway
Luxembourg Centre for Systems Biology (LCSB)
Luxembourg Immune Mediated Inflammatory Disease Research Association (LIMIDRA)
EpiPath – Severe childhood adversity is thought to be one of the strongest risk factors for three major public health problems: cardiovascular disease, upper respiratory tract infections (URTI) and mental health problems. The principal interface between the environment and the genome is epigenetic methylation of genomic DNA. Our working hypothesis is that early life adversity induces high-risk epigenetic modifications. A cohort of young adults that experienced poor early life conditions are currently being recruited.
MetCOEPs -Environmentally induced epigenetic modifications are set in place many years before the associated type 2 diabetes, major depression, schizophrenia, hypertension and cardiovascular diseases becomes detectable. MetCOEPs looks at how these entirely natural modifications to our genome influence the activity of the associated genes, and the proteins they produce. Understanding this cascade of events will allow us to better understand how our environment influences our wellbeing, and to understand how these epigenetic markers can be used to identify people at risk of many diseases, allowing for suitable early interventions that reduce the eventual disease risk.
ESPoiRe – Although rheumatoid arthritis (RA) treatment options have improved significantly over recent years, we cannot currently predict which therapeutic option would suit individual patients leading to the current “trial and error” treatment approach “testing” patients for clinical efficacy drug by drug. Preliminary evidence suggests a large role for DNA methylation in RA. Together with Luxembourg rheumatologists we will generate epigenomes from clear clinical phenotypes, and further develop the LUXIMID register together with LIMIDRA and the LCSB to improve patient stratification and treatment choice.
Featured team members
Pauline GuébelsLaboratory Technician
Jeanne Le Cleac’hPhD
Archibold MposhiPostdoctoral Fellow
Sophie MériauxLaboratory Technician
Sebastian ScheerSenior Scientist
Jonathan TurnerGroup Leader and Deputy Head Finance & Funding, Department of Infection and Immunity
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
5 months 27 days
This cookie is set by the Google recaptcha service to identify bots to protect the website against malicious spam attacks.
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Analytics" category .
The cookie is set by the GDPR Cookie Consent plugin to record the user consent for the cookies in the category "Functional".
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Necessary" category .
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Others".
Set by the GDPR Cookie Consent plugin, this cookie is used to store the user consent for cookies in the category "Performance".
Records the default button state of the corresponding category & the status of CCPA. It works only in coordination with the primary cookie.
The JSESSIONID cookie is used by New Relic to store a session identifier so that New Relic can monitor session counts for an application.
This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
Analytical cookies are used to understand how visitors interact with the website. These cookies provide information on metrics such as number of visitors, bounce rate, traffic source, etc.
The _ga cookie, installed by Google Analytics, calculates visitor, session and campaign data and also keeps track of site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognize unique visitors.
This cookie is installed by Google Analytics.
Set by Google to distinguish users.
Installed by Google Analytics, _gid cookie stores information on how visitors use a website, while also creating an analytics report of the website's performance. Some of the data that are collected include the number of visitors, their source, and the pages they visit anonymously.
Linkedin set this cookie to store information about the time a sync took place with the lms_analytics cookie.
YouTube sets this cookie via embedded youtube-videos and registers anonymous statistical data.